The vector of anti-Her2 T cell receptor (TCR) is constructed for the engineering of T cell to target Human Her2. The T cells are genetically modified through transduction with a lentiviral vector expressing Her2-specific T cell receptor. And the vector product was designed for the treatment of Breast cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-NK-2-M331-4G||Anti-ErbB2 scFv h(CD4-FcεRIγ) CARNK, pCDCAR1|
|TCR-C097Z||Murinized anti-HER2 T cell receptor (HER2-1 ), pCDTCR1|
|CAR-T-2-M550-2G||Anti-HER2 VHH h(CD28-FcεRIγ) CAR, [T]|
|CAR-MZ019||Anti-ErbB2 (Trastuzumab) h(CD28-CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC224||Lenti-ErbB2 CAR (scFv-CD28-FcεRIγ, OTI5C4) Viral Particle|
|VP-CAR-LC830||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, N29) Viral Particle|
|VP-CAR-LC223||Lenti-ErbB2 CAR (scFv-CD3ζ, OTI5C4) Viral Particle|
|CAR-MZ031||Anti-ErbB2 (C6ML3-9) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-LC252||Anti-HER2 (6D) h(CD28-41BB-CD3ζ) CAR, pCDCAR1|
|TCR-L050||Human anti-ERBB2 (ErbB2 369–377) T Cell Receptor, pMSGV|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved